Precision prevention, population health and gender medicine
Precision Prevention, Population Health & Gender Medicine Facility
The network
From risk characterisation to personalised prevention, for more equitable, inclusive and sustainable health.
The network is the part of the ecosystem dedicated to the transition from predominantly reactive medicine to proactive, predictive, preventive, personalised and participatory medicine. It brings together biomedical research, epidemiology, public health and community healthcare to promote health and healthy ageing.
Objectives
Identify individual and population risk profiles early; develop targeted prevention and screening strategies; integrate sex and gender perspectives; reduce health inequalities and generate evidence for sustainable interventions.
Facilities and technologies
Precision Prevention
Personalised strategies and risk stratification.
Population Health & Epidemiology
Cohorts, registries and molecular epidemiology.
Preventive Genomics
Genetic predisposition and polygenic models, where validated.
Gender Medicine
Analysis of sex and gender differences.
Exposomics & Environmental Health
Environmental and occupational exposures.
Nutrition & Lifestyle Medicine
Nutrition, metabolism and modifiable factors.
Digital Prevention
Sensors and longitudinal monitoring.
Precision Screening
Assessment of risk-based screening.
Healthy Ageing
Biological ageing and frailty.
Health Equity
Social determinants and equitable access.
Three integrated dimensions
Precision prevention
Integrating genomic, multi-omic, clinical, metabolic and epidemiological data to identify risk and develop validated interventions that complement universal prevention.
Population health
Cohorts, registries, biobanks and longitudinal data to study health determinants, vulnerable populations, inequalities and preventive interventions.
Gender medicine
Integrating biological sex and social gender variables, from preclinical research to healthcare practice, to ensure appropriate medicine for everyone.
Main activities
- Individual risk stratification using molecular, clinical, family and environmental data.
- Development and validation of primary and secondary prevention strategies and targeted screening.
- Integration of sex and gender into study design and biomarker validation.
- Molecular epidemiology and longitudinal cohorts.
- Digital tools and predictive models, assessed for accuracy, transferability and equity.
- Assessment of health and economic impact and inequalities in access.
Cross-cutting platforms and services
Population biobanks, multi-omics platforms, bioinformatics and AI, federated data integration systems, epidemiological registries, digital monitoring and tools for assessing health and economic impact.
Links with the other networks
| Network | Contribution |
|---|---|
| Biobank Network | Biological samples and longitudinal cohorts |
| Genomics and Multi-Omics | Molecular risk factors |
| Molecular Pathology and Digital Diagnostics | Early alterations |
| Advanced Imaging & Radiomics | Imaging biomarkers and early diagnosis |
| Cellular Models & Functional Biology | Mechanisms of susceptibility |
| Translational Therapeutics & Drug Discovery | Potential preventive drug interventions |
| Clinical Trials & Precision Medicine | Clinical validation of interventions |
| Biomarker Discovery & Validation | Validation of risk biomarkers |
| National Biomedical Data & AI Platform | Data integration and predictive modelling |
| Clinical Implementation & Hospital Integration | Translation into hospital and community healthcare pathways |
Results and impact
Would you like more information about this network?
Send an information request to the HEAL ITALIA coordination team. This form is not a request for access to healthcare or scientific services.
Request information →